Production (Stage)
C
CorMedix Inc. CRMD
$11.22 -$0.49-4.18% NASDAQ
Recommendation
Prev Close
$11.22
Volume
1,337,963
Avg Vol (90D)
1,970,528
Market Cap
$835.10M
Dividend & Yield
--
52-Week Range
$3.61 - $17.43
P/E (TTM)
49.62
EPS (TTM)
$0.2261
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages
7/10/2025 - MarketBeat
Important Notice to Long-Term Shareholders of CorMedix Inc. (NASDAQ: CRMD); Maison Solutions, Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your Behalf as Key Developments Occur in Underlying Class Actions
7/9/2025 - Globe Newswire
RBC Capital Keeps Their Buy Rating on Cormedix (CRMD)
7/7/2025 - TipRanks Financial Blog
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Your Behalf as Key Developments Occur in Underlying Class Actions
7/2/2025 - Globe Newswire
HC Wainwright Estimates CorMedix FY2027 Earnings
7/2/2025 - MarketBeat
Analysts Forecast 14% Upside For The Holdings of VFMO
7/2/2025 - ETF Channel
CorMedix (CRMD, $11.79) price exceeded its 50-day Moving Average on July 01, 2025
7/2/2025 - Tickeron - Technical Analysis
CorMedix Analyst Says Investors Could Be Further Rewarded
6/30/2025 - Benzinga
CorMedix Seems Significantly Undervalued
6/30/2025 - Seeking Alpha - Long Ideas
CorMedix Seems Significantly Undervalued
6/30/2025 - SeekingAlpha
D. Boral Capital Downgrades CorMedix (NASDAQ:CRMD) to Hold
6/30/2025 - MarketBeat
D. Boral Capital Downgrades CorMedix (NASDAQ:CRMD) to Hold
6/30/2025 - Ticker Report
CorMedix just downgraded at D. Boral Capital, here's why
6/30/2025 - The Fly
CorMedix initiated with bullish view at H.C. Wainwright, here's why
6/30/2025 - The Fly
Company News for Jun 30, 2025
6/30/2025 - Zacks Investment Research
CorMedix (CRMD, $12.5) entered Downtrend as Momentum indicator drops below 0 level on Jun 27, 2025
6/28/2025 - Tickeron - Stocks
CorMedix (CRMD, $12.5) price may climb as it broke lower Bollinger Band on Jun 27, 2025
6/28/2025 - Tickeron - Stocks
CorMedix (NASDAQ:CRMD) Shares Gap Down - Here's Why
6/27/2025 - MarketBeat
CorMedix (CRMD) Stock Declines Amid $85 Million Share Offering
6/27/2025 - GuruFocus
Cormedix Inc (CRMD) Announces $85 Million Public Offering CRMD stock news
6/27/2025 - GuruFocus
Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session
6/27/2025 - Benzinga
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
6/27/2025 - GuruFocus
CorMedix Inc. Announces Pricing of Public Offering of Common Stock CRMD Stock News
6/27/2025 - GuruFocus
S&P Futures Trade At All Time High Boosted By Trade Talks, Nike Results
6/27/2025 - Zero Hedge
CorMedix 6.605M share Spot Secondary priced at $12.87
6/27/2025 - The Fly
Income Statement
Total Revenue (TTM)
$82.55M
EBITDA (TTM)
$14.92M
EBIT (TTM)
$14.47M
Net Income (TTM)
$17.18M
Balance Sheet
Total Assets (Q)
$149.58M
Total Debt (Q)
$476.60K
Total Liabilities (Q)
$34.69M
Book Value Per Share (Q)
$1.70
Cash Flow
Cash from Operations (TTM)
-$13.57M
Cash from Investing (TTM)
$12.09M
Cash from Financing (TTM)
$32.51M
Net Change in Cash (TTM)
$31.03M
Filings
Filing Date
Tuesday, May 6, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.23
7-Day Total Return
-3.19%
30-Day Total Return
-8.18%
60-Day Total Return
51.62%
90-Day Total Return
13.91%
Year to Date Total Return
36.50%
1-Year Total Return
134.73%
2-Year Total Return
188.43%
3-Year Total Return
167.78%
5-Year Total Return
90.82%
52-week Low
Aug 13, 2024 - $3.61
52-week High
Jun 23, 2025 - $17.43
Valuation
Market Cap
$835.10M - Small Cap
Enterprise Value
$758.07M
Price/Sales (TTM)
9.38
Price/Book (Q)
6.61
Dividends and Shares
Shares Outstanding
68.98
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cormedix.com
Phone Number
908 517 9500
Address
300 Connell Drive
Berkeley Heights, NJ 07922
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product... more
NASDAQ 07/11/2025 4:00PM Eastern Quotes delayed